Works matching AU Donghang Li


Results: 34
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.

    Published in:
    CTS: Clinical & Translational Science, 2025, v. 18, n. 5, p. 1, doi. 10.1111/cts.70211
    By:
    • Li, Junyi;
    • Liao, Michael Z.;
    • Wilkins, Justin;
    • Penuel, Elicia;
    • Wang, Bei;
    • Vadhavkar, Shweta;
    • Peng, Kun;
    • Cao, Junning;
    • Li, Zhiming;
    • Zhang, Ye;
    • Li, Wenjin;
    • Li, Donghang;
    • Zhou, Mingzhu;
    • Wei, Michael C.;
    • Kwan, Antonia;
    • Zhao, Rong;
    • Li, Chunze;
    • Li, Chi‐Chung;
    • Turner, David C.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e99
    By:
    • Xiaohua Wu;
    • Jihong Liu;
    • Ruifang An;
    • Rutie Yin;
    • Yu Zhang;
    • Huaijun Zhou;
    • Aiqin He;
    • Li Wang;
    • Jieqing Zhang;
    • Ziling Liu;
    • Wei Duan;
    • Jianqing Zhu;
    • Ge Lou;
    • Guilin Chen;
    • Ying Cheng;
    • Fengxia Xue;
    • Sonja Nick;
    • Haiyan Wang;
    • Donghang Li
    Publication type:
    Article
    34